Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Ketamine Infusions vs Paravertebral Block for Rib Fracture Pain
NCT04413799Phase 1Terminated
- Sponsor
- George Washington University
- Start
- Sep 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine and ketamine in pain (2 arms), sponsored by George Washington University. Primary endpoints: Numeric Pain Score at 1 week and Oral Morphine Equivalence at 1 week. Started Sep 2020; status: terminated.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04413799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04413799.